The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Shenzhen Capital Group, Qingkong Jinxin Blue Microbiology Fund.
The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2018. The usual things for fund are deals in the range of 5 - 10 millions dollars.
Among the various public portfolio startups of the fund, we may underline Zhiyi Pharmaceutics Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
| Fund Name | Location |
| DFS Deutsche Flugsicherung | Germany, Hessen, Langen |
| E8 Angels | Seattle, United States, Washington |
| Government of Newfoundland and Labrador | Canada, Newfoundland, St. John's |
| Hongde Touzi | China, Guangdong, Shenzhen |
| Iceland Venture Studio | Gullbringusysla, Iceland, Reykjavík |
| Info Edge | India, Noida, Uttar Pradesh |
| Kangtai Insurance | - |
| Landmark Partners | Connecticut, Simsbury, United States |
| Latona Associates | - |
| Le Studio VC | France, Ile-de-France, Paris |
| MABS | Ahmedabad, Gujarat, India |
| Palm Eco-Town Development Co.,Ltd. | China, Guangdong Province, Panyu District |
| Plus Social Investment | Japan, Kyoto, Kyoto Prefecture |
| Sadot Research and Development | Israel, Tel Aviv, Tel Aviv District |
| Secocha Ventures | Florida, Miami, United States |
| Sinopharm Capital | China, Shanghai |
| Sofimac Innovation | - |
| Tau Investment Management | New York, New York, United States |
| u.ventures | Kyiv, Ukraine, Київська міська громада |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Zhiyi Pharmaceutics | $7M | 05 Sep 2018 | Guangdong Province |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Zhiyi Pharmaceutics | $7M | 05 Sep 2018 | Guangdong Province |
